Download PDF
J Knee Surg
DOI: 10.1055/a-2509-3502
Original Article

Additional Dose of Intravenous Dexamethasone Can Replace Patient-Controlled Analgesia in Pain Control after Total Knee Arthroplasty while Reducing Opioid Complications

Jisu Park 
1   Department of Orthopaedic Surgery, Seoul National University College of Medicine, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea
,
Moon Jong Chang 
1   Department of Orthopaedic Surgery, Seoul National University College of Medicine, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea
,
Tae Woo Kim
1   Department of Orthopaedic Surgery, Seoul National University College of Medicine, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea
,
Chong Bum Chang
2   Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
,
Seung-Baik Kang 
1   Department of Orthopaedic Surgery, Seoul National University College of Medicine, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

The purpose of this study was to evaluate whether intravenous (IV) dexamethasone, within the current multimodal pain management protocol, (1) could maintain postoperative pain at a comparable level without IV patient-controlled analgesia (PCA), (2) could reduce opioids-related side effects, and (3) whether an additional dose of dexamethasone on postoperative day (POD) 2 would offer further pain-relieving effect without increasing the risk of complications. A total of 178 patients (182 knees) who underwent total knee arthroplasty for osteoarthritis were included in the study. The patients were divided into Dexa 2 & PCA and Dexa 3 & NoPCA groups. From operative day to POD 5, pain visual analogue score (VAS), rescue opioids consumption, episodes of postoperative nausea and vomiting (PONV), antiemetics usage, and side effects of opioids such as postoperative urinary retention (POUR) and constipation were checked. For safety, wound complication and infection were checked. There was no difference in pain VAS between the two groups during all six perioperative days. Rescue opioids consumption was lower in Dexa 2 & PCA group. Total dosage of used opioids for six perioperative days was lower in Dexa 3 & NoPCA group. Dexa 3 & NoPCA group had less PONV and POUR. There was a marked increase in pain VAS and the use of rescue opioids from POD 1 to POD 2 in the Dexa 2 & PCA. There were no wound problems or infections in either group. Under the current multimodal pain management protocol, comparable level of postoperative pain could be achieved by dexamethasone without the need of IV PCA. By not using IV PCA, overall opioid usage was reduced, which could lead to a lower frequency of PONV and POUR. While there is still room for further research on the duration and frequency of administering dexamethasone, additional administration on POD 2 is believed to provide additional pain management benefits compared with administering only until POD 1.

Keywords

total knee arthroplasty - perioperative management - postoperative pain - postoperative nausea and vomiting - dexamethasone


Publication History

Received: 24 January 2024

Accepted: 01 January 2025

Accepted Manuscript online:
03 January 2025

Article published online:
19 March 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Akbari GA, Erdi AM, Asri FN. Comparison of fentanyl plus different doses of dexamethasone with fentanyl alone on postoperative pain, nausea, and vomiting after lower extremity orthopedic surgery. Eur J Transl Myol 2022; 32 (02) 10397
    CrossrefPubMedSearch in Google Scholar
  • 2 Goto S, Kasuya Y, Okuyama K, Ikari K, Ozaki M. Impeding factors of early rehabilitation postoperatively after rheumatoid toe arthroplasty: a single-center retrospective cohort study. JA Clin Rep 2020; 6 (01) 50
    CrossrefPubMedSearch in Google Scholar
  • 3 Choi YS, Kim TW, Chang MJ, Kang SB, Chang CB. Enhanced recovery after surgery for major orthopedic surgery: a narrative review. Knee Surg Relat Res 2022; 34 (01) 8
    CrossrefPubMedSearch in Google Scholar
  • 4 Wainwright TW, Gill M, McDonald DA. et al. Consensus statement for perioperative care in total hip replacement and total knee replacement surgery: Enhanced Recovery After Surgery (ERAS) Society recommendations. Acta Orthop 2020; 91 (01) 3-19
    CrossrefPubMedSearch in Google Scholar
  • 5 Dolin SJ, Cashman JN. Tolerability of acute postoperative pain management: nausea, vomiting, sedation, pruritus, and urinary retention. Evidence from published data. Br J Anaesth 2005; 95 (05) 584-591
    CrossrefPubMedSearch in Google Scholar
  • 6 Colvin LA, Bull F, Hales TG. Perioperative opioid analgesia-when is enough too much? A review of opioid-induced tolerance and hyperalgesia. Lancet 2019; 393 (10180): 1558-1568
    CrossrefPubMedSearch in Google Scholar
  • 7 Hah JM, Bateman BT, Ratliff J, Curtin C, Sun E. Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic. Anesth Analg 2017; 125 (05) 1733-1740
    CrossrefPubMedSearch in Google Scholar
  • 8 Lamplot JD, Wagner ER, Manning DW. Multimodal pain management in total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty 2014; 29 (02) 329-334
    CrossrefPubMedSearch in Google Scholar
  • 9 Vendittoli P-A, Makinen P, Drolet P. et al. A multimodal analgesia protocol for total knee arthroplasty. A randomized, controlled study. J Bone Joint Surg Am 2006; 88 (02) 282-289
    CrossrefPubMedSearch in Google Scholar
  • 10 Weibel S, Rücker G, Eberhart LH. et al. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. Cochrane Database Syst Rev 2020; 10 (10) CD012859
    PubMedSearch in Google Scholar
  • 11 Samuel S, Nguyen T, Choi HA. Pharmacologic characteristics of corticosteroids. J Neurocrit Care 2017; 10 (02) 53-59
    CrossrefPubMedSearch in Google Scholar
  • 12 Parente L. Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids. BMC Pharmacol Toxicol 2017; 18 (01) 1
    CrossrefPubMedSearch in Google Scholar
  • 13 Fan Z, Ma J, Kuang M. et al. The efficacy of dexamethasone reducing postoperative pain and emesis after total knee arthroplasty: a systematic review and meta-analysis. Int J Surg 2018; 52: 149-155
    CrossrefPubMedSearch in Google Scholar
  • 14 Zhuo Y, Yu R, Wu C, Huang Y, Ye J, Zhang Y. The role of perioperative intravenous low-dose dexamethasone in rapid recovery after total knee arthroplasty: a meta-analysis. J Int Med Res 2021; 49 (03) 300060521998220
    CrossrefPubMedSearch in Google Scholar
  • 15 Ruberto RA, Farah O, Lopez C, Hickernell T. Perioperative intravenous glucocorticoids in total joint arthroplasty: a systematic review. J Am Acad Orthop Surg 2023; 31 (02) e94-e106
    CrossrefPubMedSearch in Google Scholar
  • 16 Liang S, Xing M, Jiang S, Zou W. Effect of intravenous dexamethasone on postoperative pain in patients undergoing total knee arthroplasty: a systematic review and meta-analysis. Pain Physician 2022; 25 (02) E169-E183
    PubMedSearch in Google Scholar
  • 17 Lex JR, Edwards TC, Packer TW, Jones GG, Ravi B. Perioperative systemic dexamethasone reduces length of stay in total joint arthroplasty: a systematic review and meta-analysis of randomized controlled trials. J Arthroplasty 2021; 36 (03) 1168-1186
    CrossrefPubMedSearch in Google Scholar
  • 18 Wu L, Si H, Li M. et al. The optimal dosage, route and timing of glucocorticoids administration for improving knee function, pain and inflammation in primary total knee arthroplasty: a systematic review and network meta-analysis of 34 randomized trials. Int J Surg 2020; 82: 182-191
    CrossrefPubMedSearch in Google Scholar
  • 19 Hannon CP, Fillingham YA, Mason JB. et al. The efficacy and safety of corticosteroids in total joint arthroplasty: a direct meta-analysis. J Arthroplasty 2022; 37 (10) 1898-1905.e7
    CrossrefPubMedSearch in Google Scholar
  • 20 Wasko MK, Bobecka-Wesołowska K, Tomasiuk R, Kowalczewski J. Measurement of the inflammatory response in the early postoperative period after hip and knee arthroplasty. Clin Chem Lab Med 2015; 53 (11) 1785-1792
    CrossrefPubMedSearch in Google Scholar
  • 21 Lebleu J, Pauwels A, Poilvache H, Anract P, Belbachir A. Severe postoperative pain in total knee arthroplasty patients: risk factors, insights and implications for pain management via a digital health approach. J Clin Med 2023; 12 (24) 7695
    CrossrefPubMedSearch in Google Scholar
  • 22 Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain - United States, 2022. MMWR Recomm Rep 2022; 71 (03) 1-95
    CrossrefPubMedSearch in Google Scholar
  • 23 Ballstaedt LWB. Bladder Post Void Residual Volume. StatPearls; 2023
    Search in Google Scholar
  • 24 Khan MI, Khandadashpoor S, Rai Y, Vertolli G, Backstein D, Siddiqui N. Comparing analgesia on an as-needed basis to traditional intravenous patient-controlled analgesia within fast-track orthopedic procedures: a randomized controlled trial. Pain Manag Nurs 2022; 23 (06) 832-837
    CrossrefPubMedSearch in Google Scholar
  • 25 Wheeler M, Oderda GM, Ashburn MA, Lipman AG. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain 2002; 3 (03) 159-180
    CrossrefPubMedSearch in Google Scholar
  • 26 Barra MF, Kaplan NB, Balkissoon R, Drinkwater CJ, Ginnetti JG, Ricciardi BF. Same-day outpatient lower-extremity joint replacement: a critical analysis review. JBJS Rev 2022; 10 (06)
    CrossrefPubMedSearch in Google Scholar
  • 27 Denham M, Donovan K, Wetoska N. et al. Effects of dexamethasone on postoperative urinary retention after laparoscopic inguinal hernia repair. Surg Endosc 2019; 33 (09) 3008-3013
    CrossrefPubMedSearch in Google Scholar
  • 28 Broderick RC, Li JZ, Blitzer RR. et al. A steady stream of knowledge: decreased urinary retention after implementation of ERAS protocols in ambulatory minimally invasive inguinal hernia repair. Surg Endosc 2022; 36 (09) 6742-6750
    CrossrefPubMedSearch in Google Scholar
  • 29 Schimmer BP, Parker KL. Adrenocorticotropic Hormone; Adrenocortical Steroids and Their Synthetic Analogs; Inhibitors of the Synthesis and Actions of Adrenocortical Hormones. Goodman & Gilmans the Pharmacological Basis of Therapeutics. 11th ed.. New York: McGraw Hill; 2006: 1587-1612
    Search in Google Scholar
  • 30 Saini MK, Reddy NR, Reddy PJ, Thakur AS, Reddy CD. The application of low-dose dexamethasone in total knee arthroplasty: finding out the best route and dosage schedule. Arch Orthop Trauma Surg 2023; 143 (02) 1005-1012
    CrossrefPubMedSearch in Google Scholar
  • 31 Lei Y, Huang Z, Huang Q, Pei F, Huang W. Dose optimization of intravenous dexamethasone for total knee arthroplasty: when two is not better than one. Arch Orthop Trauma Surg 2022; 142 (04) 665-672
    CrossrefPubMedSearch in Google Scholar
  • 32 Kim JK, Ro DH, Lee HJ, Park JY, Han HS, Lee MC. Efficacy of systemic steroid use given one day after total knee arthroplasty for pain and nausea: a randomized controlled study. J Arthroplasty 2020; 35 (01) 69-75
    CrossrefPubMedSearch in Google Scholar
  • 33 Xu H, Zhang S, Xie J, Lei Y, Cao G, Pei F. Multiple doses of perioperative dexamethasone further improve clinical outcomes after total knee arthroplasty: a prospective, randomized, controlled study. J Arthroplasty 2018; 33 (11) 3448-3454
    CrossrefPubMedSearch in Google Scholar
  • 34 Lei Y, Huang Q, Xu B, Zhang S, Cao G, Pei F. Multiple low-dose dexamethasone further improves clinical outcomes following total hip arthroplasty. J Arthroplasty 2018; 33 (05) 1426-1431
    CrossrefPubMedSearch in Google Scholar
  • 35 Armaghani SJ, Lee DS, Bible JE. et al. Preoperative opioid use and its association with perioperative opioid demand and postoperative opioid independence in patients undergoing spine surgery. Spine 2014; 39 (25) E1524-E1530
    CrossrefPubMedSearch in Google Scholar
  • 36 Pivec R, Issa K, Naziri Q, Kapadia BH, Bonutti PM, Mont MA. Opioid use prior to total hip arthroplasty leads to worse clinical outcomes. Int Orthop 2014; 38 (06) 1159-1165
    CrossrefPubMedSearch in Google Scholar